Appclon has newly appeared among the top searched stocks.
As of 2:32 PM on the 11th, Appclon is trading at 38,700 KRW, down 5.15% from the previous day. This represents an 11.85% increase compared to August 19. Appclon is known as the only domestic bio new drug development specialist among listed companies.
Over the past five days, individual investors have net purchased 108,332 shares, while foreigners and institutions have net sold 8,489 shares and 90,359 shares, respectively.
On September 10, Appclon became a market issue with the headline "Soaring with wings... COVID-19 treatment and blood cancer treatment..."
※Source: AI Investment Assistant AI Rasero
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
